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BACKGROUND

METHODS

RESULTS

While rates of chronic noncancer pain ( CNCP - pain that
persists longer than three months and is not secondary to
cancer) are similar across developed countries, the U.S.
consumes almost 100% and 81% of the world’s supply of
hydrocodone and oxycodone, respectively.

Retrospective chart review of patients ≥18 years of age who
were prescribed opioids for ≥90 days for CNCP and managed at
one of two academic family practice clinics.

A Comparison of Patient Demographics: Baseline
(pre-intervention) versus 12 month (post-intervention)

Chart review was performed prior to, as well as 6 and 12
months following, the educational intervention.
• Demographic, health, and social information were collected.

In the last two decades, opioid abuse has become a major
problem in the US.
Opioid analgesics are currently the source of more overdose
deaths nationwide than heroin and cocaine combined.
Historically, the literature has not supported training
interventions with guidelines, recommendations and education
to modify primary care provider’s (PCP’s) behaviors on opioid
prescribing.

OBJECTIVES
(1) To determine if educating PCP’s on safe opioid prescribing
increases the level of appropriateness on use of opioids for
CNCP.
(2) To minimize the training gap on chronic pain management
for clinicians at two academic family practice clinics.

An opioid appropriateness score was calculated based on
documentation of nine items:
Details on drug use, substance abuse or detox
Pain contract/agreement within past year
Urine drug screen within last year
Visit to discuss CNCP at least every six months
Discussions on expectations about pain
level/therapeutic/functional goals
Use of non-opioid medications
Imaging/EMG/labs to identify pain generator
Consultation with a specialist if on methadone, > 120
MDE or >2 comorbid psych conditions
Use of non-pharmacologic methods (PT, OMT)
Descriptive statistics were generated. Comparisons utilized Chisquare, Fisher exact, and Mann-Whitney tests, as well as
regression, as appropriate.
The educational intervention included:
Lecture series
Posters
Pocket cards/flyers
Electronic medical record tools
Patient education
Bi-monthly educational emails
Discussions during meetings
Guidelines/Policy development
Topics discussed during lecture series:
 Opioid physiology and effects
 Identifying opioid abuse in chronic pain patients
 Interacting with the drug-seeking patient
 Pharmacological approaches to pain
 Prescribing opiates responsibly

History of psychiatric conditions:

History of illegal drugs or alcohol use:

Opioids used:
• Overall, pre- and post-intervention level of appropriateness
were significantly different (p<0.0001) with means increasing
from 5.54 pre-intervention to 6.29 post-intervention. Both
clinics had significant improvement from baseline (both pvalues < 0.003), one clinic showed improvement within 6
months following start of clinician education.

Non-Opioids used:

• The intervention was associated with a sustained (> 6
months) improvement in the level of appropriateness for
opioid prescription at both clinics.
• Statistically significant increases in appropriateness score
items post-intervention included:
Discussions on expectations about pain level and
therapeutic/functional goals (p<0.0001)
Use of non-pharmacologic methods (PT, OMT; p=0.027)

Types of pain:

Sought specialty care for:

CONCLUSIONS
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Provider education on best practices while treating CNCP is
associated with increase in the level of appropriateness on the
use of opioids for this problem. Lack of standardized training on
individual and institutional level is a major challenge for
clinicians treating CNCP. Tools and protocols on CNCP
management has the potential to promote more comprehensive
and integrated pain treatment while minimizing opioid misuse.
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